Dihydropyrazole-Carbohydrazide Derivatives with Dual Activity as Antioxidant and Anti-Proliferative Drugs on Breast Cancer Targeting the HDAC6

Breast cancer (BC) is the most frequently diagnosed cancer and is the second-most common cause of death in women worldwide. Because of this, the search for new drugs and targeted therapy to treat BC is an urgent and global need. Histone deacetylase 6 (HDAC6) is a promising anti-BC drug target associ...

Descripción completa

Detalles Bibliográficos
Autores principales: Balbuena-Rebolledo, Irving, Rivera-Antonio, Astrid M., Sixto-López, Yudibeth, Correa-Basurto, José, Rosales-Hernández, Martha C., Mendieta-Wejebe, Jessica Elena, Martínez-Martínez, Francisco J., Olivares-Corichi, Ivonne María, García-Sánchez, José Rubén, Guevara-Salazar, Juan Alberto, Bello, Martiniano, Padilla-Martínez, Itzia I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9230091/
https://www.ncbi.nlm.nih.gov/pubmed/35745608
http://dx.doi.org/10.3390/ph15060690

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9230091/
https://www.ncbi.nlm.nih.gov/pubmed/35745608
http://dx.doi.org/10.3390/ph15060690

Ejemplares similares